Clinical Trial Update: DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot Study [Phase 1]

View source ↗

Summary

Open-label, adaptive-design Phase 1 trial evaluating DEC033 for mild to moderate eczema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• DEC033

Snippet

Sponsor: Medicus Research, LLC | Conditions: Eczema | Phase 1 | Status: COMPLETED